Can-Fite Stock Jumps After Japan Patent Boosts Obesity Drug Case BY Akanksha Bakshi • June 26, 2026June 26, 2026 Can-Fite BioPharma Ltd. (NYSE:CANF), a clinical-stage biotech, saw its shares jump on Friday after the company secured a Japanese patent allowance for its anti-obesity technology. The Japanese Patent[...] Read more